Absorption of drugs into the eye requires good pre-corneal New Delhi and sodium alginate was obtained penetration and prolonged contact time with corneal tissues.
commercially (Thomas Baker Chemicals Ltd., Mumbai) Ideally, the formulation should be able to sustain drug and all other chemicals and reagents used were of release and to maintain contact with the eye for extended analytical grade. periods of time. The extent of absorption into the eye is severely limited by the physiological constraints such as Preparation of the in situ gelling system: reflex tearing and blinking 1 . Further, drug loss occurs due to Indomethacin (passed through BSS # 200) dispersion (1% tear turnover, solution drainage by gravity and binding of w/v) was prepared in sterile 0.05 M acetate buffer (pH drugs to proteins and other components of tear. As a result, 5.0) and in sterile phosphate buffer (pH 7.4) made isotonic typically only 1-2% of the instilled drug is bioavailable 2 . To with saline. Alginate, at solution concentrations of 0.5-2% overcome these problems certain novel approaches have w/v, was prepared in the same buffer and sterilized by been investigated [3] [4] [5] [6] [7] [8] [9] [10] . The solid ocular inserts have overcome autoclaving. The two liquids were combined and stirred the problems of low bioavailability, but still are not popular for 7 h under aseptic conditions to obtain a uniform because of foreign body sensation and high cost and are dispersion ( Table 1) . The preparations were filled into generally not considered friendly for users.
presterilized amber colored neutral glass vials, which were stoppered with presterilized LDPE, sealed and The concept of in situ forming gels came into existence in refrigerated (4-8°) until usage. the early 80s 11 and such systems have been investigated using phase-transition polymers [12] [13] [14] [15] [16] . Sodium alginate has been used extensively to form polymeric dispersions in buffers that typically show low viscosity up to pH 5 and coacervate in contact with tear and thus form gels 17 . In the present study an in situ gelling preparation of indomethacin in sodium alginate has been investigated, which holds promise as a more patient acceptable dosage form.
MATERIALS AND METHODS
Indomethacin was generously gifted by Jagsonpal Ltd., www.ijpsonline.com
Drug content uniformity:
The vials containing the preparations were shaken for a few minutes and 100 µl of the preparations were transferred to 25 ml volumetric flasks with a micro-pipette. Phosphate buffer (pH 7.4) was added in small portions (5 ml), shaken to dissolve the contents, volume was adjusted to 25 ml, and the solutions were assayed for indomethacin content at 319.5 nm (Shimadzu-1601, Japan), using the contents of at least 6 vials.
Determination of viscosity:
The test preparation (2 ml) was placed in a circular Teflon ® cup (2.5 cm i.d. × 1.2 cm depth). This was in turn placed on an inverted USP basket kept inside a 250 ml beaker. Dissolution medium (200 ml of simulated tear of composition 1) was placed in the beaker and stirred with a star-headed magnetic bead at 60 rpm. Temperature of 37±0.5 0 was maintained throughout the study. Dissolution samples (5 ml) were withdrawn as a function of time, and the withdrawn volume was replaced with pre-warmed buffer. The indomethacin content in the dissolution samples was determined as described earlier.
The viscosities of the various batches of alginate based systems was studied on a cone (0.8°) and plate
RESULTS AND DISCUSSION
Brookefield viscometer using spindle cp 40 thermostated at a temperature of 35±1°. A typical run comprised of
The results (Table 1) indicated that the indomethacin changing the angular velocity from 0.5 to 100 rpm at a contents in the formulations were within the limits of 100±5 controlled ramp speed. After 0.1 min at 0.5 rpm, the %. Sterility tests showed that all the samples were sterile. velocities were increased to 100 at the same controlled Viscosities of the fabricated in situ gel forming systems ramp speed with 0.1 min hold time at each rpm value.
were determined before and after sterilization. The The hierarchy of the angular velocity was reversed at results showed 31-50% reduction in the viscosities after the same ramp speed with a similar hold time of 0.1 min.
sterilization by autoclaving. The percentage reduction in The average of the two readings was used to calculate the viscosities of the batches prepared in acetate buffer (pH 5.0) was more than the batches prepared in phosphate buffer (pH 7.4) (pH of tear), thus indicating In vitro gelation studies:
the tendency of sodium alginate to coacervate at The gelation studies were conducted in gelation cells, physiological pH weak gelation in 2 to 3 min in both compositions of the and STC2) 18 . STC1 contains sodium chloride 0.67 g, simulated tear (Table 1) , whereas at 1% underwent sodium bicarbonate 0.20 g, calcium chloride dihydrate instantaneous but weak gelation. Alginates at higher 0.008 g and distilled water q.s. to 100 ml, while STC2 concentrations (1.5 and 2%) showed instantaneous contains bovine serum albumin (fraction V) 0.268 g, gelation. lysozyme 0.268 g, δ-globulin 0.134 g, D-glucose 0.650 g, sodium chloride 0.650 g, calcium chloride dihydrate 0.008
On visual inspection, the alginate eye drops showed the and distilled water q. s. to 100 ml. Within the cell located formation of a translucent matrix on addition to the at the bottom was a 250 µl transparent cup to hold the gel gelation medium of composition 1, while the resultant the viscosity.
sample in place after its formation. An aliquot of the alginate-indomethacin preparation (100 µl) was carefully placed in the cavity of the cup using a micropipette, and 2 ml of the respective gelation solution was slowly ovulated on the test preparation. Gelation was determined by visual inspection, and graded as slow gelation (+), immediate gelation which remains for a 2-3 h (++) and immediate stiff gelation, which remains for extended period of time (+++). Sterility test was performed using the Alternate Thioglycollate Medium (USP XXIII).
In vitro release studies:
The drug release kinetics of the prepared formulations was studied using a modified method reported earlier 19 .
matrix had an opaque appearance in the medium of composition 2. The difference in appearance of the two matrices suggested that gelation proceeds by two different mechanisms. In the former, presumably gelation was due to ionic cross-linking of the alginate chains by the divalent cation, forming the egg box model 20 . In STC2, in addition to the cross linking by the divalent cation, the alginate could have complexed with the proteins in the medium to form a polyelectrolyte complex, which precipitates out of the solution. Formation of such complexes is well known especially for the alginate-poly (L-lysine) complex 21 . These complexes have shown physical properties different from the calcium cross-linked matrices, such as stability in aqueous solutions and permeability to various molecules. In general, matrices based on these poly-electrolyte complexes are less sensitive to dilution or ion-exchange reactions and maintain their structure under physiological condition 22 .
At relatively lower polymer concentrations, the rates of gelation were low, hence not suitable for ophthalmic formulations, as they might be removed from the cul-de sac by the tear and blinking before gelation occurs. The formation of a strong gel is contingent on a short gelation time of the delivery system upon instillation into the eye, is a well known vehicle with a low viscosity up to pH 5.0 and coacervation occurs at pH 7-7.4.
The release profiles of the concerned batches are shown in figs. 1 and 2. The release from these batches followed zero-order kinetics predominantly, with the exception of batches A 5 and P 3 which followed Higuchi type release kinetics, as evidenced by the r 2 values shown in Table 2 . Indomethacin release from the batches with lower polymer concentrations (batches A 1 and P 1 ) was higher than those with higher polymer concentrations (batches A 5 T h i s and polymer concentrations of 1.5-2% fulfill this criterion. Thus, such vehicles will not be susceptible to drainage from the eye as seen in the case of ophthalmic solutions, and will have a longer residence time.
The gelling systems were prepared using both acetate buffer (pH 5.0) and phosphate buffer (pH 7.4) in order to examine the effect of pH on the release properties of the drug from the corresponding batches, as sodium alginate and P 5 ) containing 2% (w/v) of sodium alginate. This was presumably due to their higher extent of gelation in the simulated tear. Moreover, batches A underwent slow gelation showed an initial high burst release of more than 20% of the loaded drug within 1 h, while the fast gelling matrices did not show any burst release. It is expected that the dissolution of the gels sin cul-de-sac will proceed more slowly than that seen in the in vitro experiments due to low resident volume of the www.ijpsonline.com lacrimal fluid in the human eye, being 7.5-10 µl 23 . Consequently, the in vivo drug release from these systems could occur primarily by diffusion over a long duration of time, at least similar to, if not greater, than that seen in the in vitro experiments. Thus, in our opinion, the presence of the released drug in the precorneal region for long periods of time will significantly enhance the bioavailability of the drug.
A significant difference between the drug release from the batches prepared with acetate and phosphate buffers, 2%, and will be susceptible to drainage from the eye as seen in the case of ophthalmic solutions.
In addition to the ionotropic gelling of alginate, its mucoadhesivity is also likely to contribute to enhancement of retention time. Although zero-order drug release from alginate gel systems is not expected, our findings point to the possibility of this type of drug release. Apparently in cases where the gel, once formed, attaches itself to the ocular tissues, and remains so for extended periods of time, the slow erosion of the alginate gel provides for a pH 5.0 and pH 7.4, respectively was observed, being constant diffusional path length, with resultant zero-order higher from batches prepared in acetate buffer pH 5.0.
release characteristics. The lower viscosities of the systems in acetate buffer with comparison to the batches prepared in phosphate
